We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Primary Care Physicians Underutilize Nonantibiotic Prophylaxis for Recurrent UTIs
Researchers surveyed 40 primary care physicians at one academic medical center and found that 96% of primary care physicians prescribe vaginal estrogen therapy for recurrent UTI prevention. Estrogen deficiency and urinary retention are strong contributors to infection. However, 78% of physicians surveyed said they had never prescribed methenamine hippurate, and 85% said they had never prescribed D-mannose. Full Access: Medscape
Any Combination of Hypertension Drugs Can Work in Underserved Groups
In TOPSPIN, almost 2,000 adults were randomly assigned to one of three treatment groups. All three combinations had a good safety profile; less than 3% of study participants ended treatment because of adverse effects related to the medications. The message from this trial is that physicians can use any combination of these medications to treat hypertension in patients and can choose whichever is most appropriate based on availability and cost. Full Access: Medscape
COVID-19 Deaths Drop, but Mortality Data Shows Room for Prevention
While SARS-CoV-2 infections continue to influence trends in U.S. death rates, COVID-19 is no longer among the nation’s top three killers. The tragic trio are heart disease, cancer and unintentional injury, showing substantial room for America’s physicians to play a role in preventing disease and saving lives. Full Access: AMA
Severe and Fatal Rocky Mountain Spotted Fever After Exposure in Tecate, Mexico — California, July 2023–January 2024
During July 2023–January 2024, six cases of RMSF in persons with exposure were reported to the California Department of Public Health; three patients died. This outbreak highlights a newly recognized location in Baja California with high RMSF risk. Increased awareness of RMSF among healthcare clinicians on both sides of the border between the U.S. and Mexico would facilitate prompt treatment and help prevent fatalities. Full Access: CDC
Notifications
